Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Shimadzu Corporation, MacCoss Lab of Biological Mass Spectrometry, UW Collaborate

Published: Monday, June 16, 2014
Last Updated: Monday, June 16, 2014
Bookmark and Share
The companies will leverage the power of ASCENT™ clinical solutions on ultra-fast mass spectrometry platforms.

Shimadzu and Indigo BioSystems today announced a partnership to develop and market mass spectrometry solutions that simplify and accelerate clinical data acquisition and data review for applications in clinical research, forensic toxicology and new drug development.

Under the terms of the agreement, Shimadzu is combining its ultra-fast mass spectrometry platforms with Indigo BioSystems's expert system software. ASCENTTM clinical analysis software is a comprehensive and powerful data analysis suite that interprets visual data results from instruments and automatically reviews the data for problematic results. Results are delivered quickly, consistently, and reliably.

ASCENT supports the scientist by automatically analyzing and reporting correct data, and flagging only the outliers for expert review. ASCENT™ speeds sample analysis by automating peak selection and peak area fitting. ASCENT also includes assay-specific quality assurance rules, which allow peaks to be automatically tested for quality. ASCENT operates using a web-browser interface requiring no software to be installed on computers in order to perform quantitative analysis.

Patrick Armstrong, Director of Shimadzu Scientific Instrument’s R&D department said, “Indigo BioSystems’ tools for high-throughput, automated data analysis are highly developed with an impressive list of advanced features, and greatly simplify clinical laboratory workflows,” adding that, “We are excited to work with Indigo to leverage powerful ASCENT™ tools on Shimadzu ultra-fast mass spectrometry platforms”.

Dr. Randall Julian, CEO of Indigo BioSystems said, “Our partnership with Shimadzu will result in tighter integration between their excellent ultra-fast LC-MS/MS and our automated analysis software ASCENT. This collaboration allows production labs to achieve maximum efficiency, superior quality, and rapid turnaround time. Shimadzu instruments, in combination with the ASCENT software, create a high-throughput, intelligent, production system.”



Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Shimadzu Establishes Latin American Subsidiary
Uruguayan subsidiary will strengthen company's sales and distribution whilst providing better support for customers and distributors in Central and South America.
Tuesday, November 12, 2013
Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration
Shimadzu and PDI will develop software tools for global profiling using high mass accuracy MSn data.
Monday, July 02, 2007
Scientific News
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launch of a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!